Alzheimer's Disease: Lifecycle Pharma Forecast, 2012-2035 – Europe

Alzheimer's Disease: Lifecycle Pharma Forecast, 2012-2035 – Europe

SlideScript's Lifecycle Pharma Forecast reports deliver essential therapy area benchmarking data and quantitative market estimates projected across multiple regions and individual countries. Data-rich tables enable rapid understanding of market values, product revenue potential and pricing comparisons over a patentable 20-year period.

Insights and projections facilitate, aid, and validate commercial activities related to pricing and reimbursement, market access, health economics modelling, business development, or licensing.

Benefits of this publication include:

• Country-specific epidemiology: prevalence and disease populations
• Retail pricing indices across regions and countries
• Market forecasts to 2035
• Price-point forecasts to 2035
• Leading product revenues to 2012
• Comparative value-based disease market outlook by region
• Insight into market dynamics across countries
• Summative market values across territories and age groups
• Treatment stratification effects on pricing
• Revenue projections based on dosing regimens

This report is essential to:

• Support corporate strategy and planning
• Determine or explore pricing models, health economics, pricing and reimbursement
• Validate proprietary data, key assumptions, introducing to target markets
• Evaluate national/regional pricing strengths and weaknesses
• Benchmark data against market thresholds

• i. About SlideScript Pharma
• 1. FRANCE
• 2. GERMANY
• 3. ITALY
• 4. SPAIN
• 5. UNITED KINGDOM
• 6. DENMARK
• 7. PORTUGAL
• 8. NORWAY
• 9. SWEDEN
• List of Tables
  • 1. FRANCE
    • Table 1. Alzheimer's Disease: France - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
    • Table 2. Alzheimer's Disease: France - Treatment Stratification and Market Forecast (Euros €), 2012-2019
    • Table 3. Alzheimer's Disease: France - Market Forecast (Euros €), 2012-2035
    • Table 4. Alzheimer's Disease: France - Product Revenue Forecast (Euros €) 2012-2035
    • Table 5. Alzheimer's Disease: France - Product Revenue Forecast (Euros €) 2012-2035
    • Table 6. Alzheimer's Disease: France - Product Revenue Forecast (Euros €) 2012-2035
  • 2. GERMANY
    • Table 7. Alzheimer's Disease: Germany - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
    • Table 8. Alzheimer's Disease: Germany - Treatment Stratification and Market Forecast (Euros €), 2012-2019
    • Table 9. Alzheimer's Disease: Germany - Market Forecast (Euros €), 2012-2035
    • Table 10. Alzheimer's Disease: Germany - Product Revenue Forecast (Euros €) 2012-2035
    • Table 11. Alzheimer's Disease: Germany - Product Revenue Forecast (Euros €) 2012-2035
    • Table 12. Alzheimer's Disease: Germany - Product Revenue Forecast (Euros €) 2012-2035
  • 3. ITALY
    • Table 13. Alzheimer's Disease: Italy - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
    • Table 14. Alzheimer's Disease: Italy - Treatment Stratification and Market Forecast (Euros €), 2012-2019
    • Table 15. Alzheimer's Disease: Italy - Market Forecast (Euros €), 2012-2035
    • Table 16. Alzheimer's Disease: Italy - Product Revenue Forecast (Euros €) 2012-2035
    • Table 17. Alzheimer's Disease: Italy - Product Revenue Forecast (Euros €) 2012-2035
    • Table 18. Alzheimer's Disease: Italy - Product Revenue Forecast (Euros €) 2012-2035
  • 4. SPAIN
    • Table 19. Alzheimer's Disease: Spain - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
    • Table 20. Alzheimer's Disease: Spain - Treatment Stratification and Market Forecast (Euros €), 2012-2019
    • Table 21. Alzheimer's Disease: Spain - Market Forecast (Euros €), 2012-2035
    • Table 22. Alzheimer's Disease: Spain - Product Revenue Forecast (Euros €) 2012-2035
    • Table 23. Alzheimer's Disease: Spain - Product Revenue Forecast (Euros €) 2012-2035
    • Table 24. Alzheimer's Disease: Spain - Product Revenue Forecast (Euros €) 2012-2035
  • 5. UNITED KINGDOM
    • Table 25. Alzheimer's Disease: UK - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
    • Table 26. Alzheimer's Disease: UK - Treatment Stratification and Market Forecast (Euros €), 2012-2019
    • Table 27. Alzheimer's Disease: UK - Market Forecast (Euros €), 2012-2035
    • Table 28. Alzheimer's Disease: UK - Product Revenue Forecast (Euros €) 2012-2035
    • Table 29. Alzheimer's Disease: UK - Product Revenue Forecast (Euros €) 2012-2035
    • Table 30. Alzheimer's Disease: UK - Product Revenue Forecast (Euros €) 2012-2035
  • 6. DENMARK
    • Table 31. Alzheimer's Disease: Denmark - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
    • Table 32. Alzheimer's Disease: Denmark - Treatment Stratification and Market Forecast (Euros €), 2012-2019
    • Table 33. Alzheimer's Disease: Denmark - Market Forecast (Euros €), 2012-2035
    • Table 34. Alzheimer's Disease: Denmark - Product Revenue Forecast (Euros €) 2012-2035
    • Table 35. Alzheimer's Disease: Denmark - Product Revenue Forecast (Euros €) 2012-2035
    • Table 36. Alzheimer's Disease: Denmark - Product Revenue Forecast (Euros €) 2012-2035
  • 7. PORTUGAL
    • Table 37. Alzheimer's Disease: Portugal - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
    • Table 38. Alzheimer's Disease: Portugal - Treatment Stratification and Market Forecast (Euros €), 2012-2019
    • Table 39. Alzheimer's Disease: Portugal - Market Forecast (Euros €), 2012-2035
    • Table 40. Alzheimer's Disease: Portugal - Product Revenue Forecast (Euros €) 2012-2035
    • Table 41. Alzheimer's Disease: Portugal - Product Revenue Forecast (Euros €) 2012-2035
    • Table 42. Alzheimer's Disease: Portugal - Product Revenue Forecast (Euros €) 2012-2035
  • 8. NORWAY
    • Table 43. Alzheimer's Disease: Norway - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
    • Table 44. Alzheimer's Disease: Norway - Treatment Stratification and Market Forecast (Euros €), 2012-2019
    • Table 45. Alzheimer's Disease: Norway - Market Forecast (Euros €), 2012-2035
    • Table 46. Alzheimer's Disease: Norway - Product Revenue Forecast (Euros €) 2012-2035
    • Table 47. Alzheimer's Disease: Norway - Product Revenue Forecast (Euros €) 2012-2035
    • Table 48. Alzheimer's Disease: Norway - Product Revenue Forecast (Euros €) 2012-2035
  • 9. SWEDEN
    • Table 49. Alzheimer's Disease: Sweden - Prevalence, Treatment Population, Leading Product Revenues, and Pricing Index
    • Table 50. Alzheimer's Disease: Sweden - Treatment Stratification and Market Forecast (Euros €), 2012-2019
    • Table 51. Alzheimer's Disease: Sweden - Market Forecast (Euros €), 2012-2035
    • Table 52. Alzheimer's Disease: Sweden - Product Revenue Forecast (Euros €) 2012-2035
    • Table 53. Alzheimer's Disease: Sweden - Product Revenue Forecast (Euros €) 2012-2035
    • Table 54. Alzheimer's Disease: Sweden - Product Revenue Forecast (Euros €) 2012-2035